Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00532103 · ClinicalTrials.gov registry record
Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 300
- Enrollment target
NCT00532103: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00532103 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00532103 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when doses are increased in patients with major depressive disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-02 |
What the finished NCT00532103 record still lists
NCT00532103 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00532103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00532103 about?
NCT00532103 is a clinical study titled "Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression". This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when doses are increased in patients with major depressive disorder.
What is the current status of trial NCT00532103?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2007-07. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00532103?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia